Palm Springs Community Health Center | Miami Lakes, FL

Research site

(Unclaimed)

Location

15495 Eagle Nest Lane Suite #260, Miami Lakes, Florida, United States of America

Site insights

Top conditions

Top treatments

S-892216

Molnupiravir

Amlitelimab

CX11

PF-07817883

RGT001-075

Obeldesivir

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

7 of 15 total trials

Locations recently updated

A Clinical Study of Molnupiravir to Prevent Severe Illness From Coronavirus Disease 2019 (COVID-19) in People Who Are High Risk (MK-4482-023) (MOVe-NOW)

Researchers are looking for other ways to prevent severe illness from COVID-19. COVID-19 is a virus that most often causes mild flu or cold-like symp...

Enrolling

Coronavirus Disease (COVID-19)

Drug: Placebo

Drug: Molnupiravir

A Study to Evaluate the Efficacy and Safety of CX11 Tablets in Overweight/Obese Participants

This is a multicenter, randomized, double-blind, placebo-controlled Phase 2 clinical study:* To evaluate the efficacy of different dose levels of CX1...

Active, not recruiting

Obesity

Other: Placebo

Drug: CX11

A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab in Participants Aged 12 Years and Older With Moderate-to-severe Atopic Dermatitis on Background Topical Corticosteroids (SHORE)

This is a parallel group, Phase 3, multinational, multicenter, randomized, double-blind, placebo controlled, 3-arm study for treatment of participant...

Active, not recruiting

Dermatitis Atopic

Drug: Topical calcineurin inhibitors

Drug: Amlitelimab

A Study to Learn About How the Flu and COVID-19 Vaccines Act in Healthy People

The purpose of this study is to learn about how the flu and COVID vaccines act when given alone or when mixed together.This study is seeking healthy...

Enrolling

COVID-19 (Coronavirus Disease 2019)

Influenza

Biological: Licensed Influenza Vaccine 2

Biological: Licensed Influenza Vaccine 1

DUVAX: A Phase 1 Alzheimer's Vaccine Study Targeting Amyloid-Beta and Tau (DU-PRISM)

This Phase 1 study will test the safety and immune response of the investigational vaccine DUVAX in healthy adults. Participants will be randomly ass...

Begins enrollment this month

Alzheimer Disease

Preclinical Alzheimer's Disease

Biological: DUVAX 200 µg

Biological: Placebo (Adjuvant only)

Immuno-bridging and Broadening Study of a Whole, Inactivated COVID-19 Vaccine BBV152 in Healthy Adults

A randomized, observer-blind, placebo-controlled immuno-bridging, and broadening study to demonstrate the equivalence of the immune response between...

Enrolling

COVID-19

Biological: BBV152

Study of Once-Daily Oral RGT001-075 Compared With Placebo in Adults With Obesity or Are Overweight With Weight-Related Health Conditions (COMO-1)

This is a phase 2, 36-week randomized, double-blind, placebo-controlled, parallel arm study that will evaluate the safety, tolerability, weight loss...

Active, not recruiting

Obesity or Overweight

Drug: Placebo Comparator

Drug: RGT001-075